• Osteoporotic fractures have a devastating impact on people with osteoporosis and their families.
• Osteoporotic fractures cost the UK economy in excess of £2 billion per year.¹

Are you confident that your patients at risk of fracture are being identified and receiving appropriate care?

Several recent guidelines have been developed for the treatment of osteoporosis, and the recommendations include:

• Women with a prior fragility fracture should be considered for treatment and should have a DXA scan.
• Clinical risk factors can also be assessed using the FRAX^TM tool.
• Where appropriate, ensure suitable treatment is prescribed and that the patient complies with treatment.

Further information on all these guidelines is available on a new online resource which also provides additional support and resources to improve the quality of patient care and reduce associated costs, please visit www.breakingpoint.org  for more help today.

Amgen and GlaxoSmithKline have provided funding for the development of the Breaking Point report and website.

Funding support has involved contributing honoraria to the editorial board, advisory board members and medical writer and payment to a public relations agency in respect of project management support.

References
1. National Osteoporosis Society. Protecting fragile bones: A strategy to reduce the impact of osteoporosis and fragility fractures in England/Scotland/Wales/Northern Ireland. 2009. Available for download from: www.nos.org.uk/page.aspx?pid=818 [Last accessed 02-06-2011]

This is a promotional feature article that has been produced by Breaking Point.